logo
More than 10 years later, Flint declares its water safe after replacing lead pipes, but health issues and doubts persist

More than 10 years later, Flint declares its water safe after replacing lead pipes, but health issues and doubts persist

CNNa day ago
Melissa Mays said she may never trust the water from her Flint, Michigan, tap again.
In the 11 years since the city's historic water crisis, Mays said she has battled Legionnaires' disease, autoimmune and seizure disorders, high blood pressure, and other illnesses. Her youngest son, now 21, experienced speech delays as a child after unknowingly drinking lead-poisoned water, she added.
Mays still believes the plumbing lines in her neighborhood are contaminated. The water from her faucets is often yellow and has a foul smell unless it is filtered, she said.
So when Michigan submitted a progress report to a federal court in July stating it had completed the replacement of 11,000 lead pipes, restored 28,000 damaged properties, and the US Environmental Protection Agency lifted its emergency order on Flint's drinking water earlier this year, Mays said she remained skeptical.
Mays is among many Flint residents who said they have lost faith in lawmakers and elected officials after the water crisis devastated their community in 2014, and they still refuse to drink or bathe in the water without a filter.
'Flint is not fixed,' said Mays, a leading activist in the fight for clean, safe drinking water in Flint. 'And we are not going to shut up and go away. Fix us properly because it's the right thing to do.'
Federal officials, however, insist Flint's water is now safe and meets the requirements of the EPA's Safe Drinking Water Act.
'Lifting this emergency order is a cause for great celebration for residents of Flint who worked so hard and sacrificed so much to get to this point,' EPA Administrator Lee Zeldin said in May. 'Even though the emergency order is lifted, all levels of government must continue to stay in contact and work closely to be a continued resource for the Flint community and ensure their water remains pristine.'
Flint's water crisis began in 2014 when local and state officials switched the city's water supply from Detroit's system to the Flint River as part of a cost-cutting measure.
Officials detected bacteria in the water in August 2014. Warnings were issued to residents, and subsequent testing revealed dangerous levels of lead in the water. Local pediatricians also raised concerns about a growing number of children with elevated lead levels in their blood.
But Flint did not switch its water supply back to Detroit until October 2015.
A landmark settlement reached in March 2017 required the replacement of every Flint resident's lead pipe after residents and nonprofit groups sued city and state officials for exposing the community to contaminated drinking water.
The settlement also required officials to conduct tap water tests, distribute faucet filters and provide education on their use, and fund health programs for residents affected by the contaminated water.
In a separate $600 million settlement, the state of Michigan agreed in 2020 to make direct payments to Flint residents affected by the water crisis. Nearly 80% of the funds are reserved for people who were under 18 when the crisis began.
Flint's water crisis prompted a national call to action, with former President Joe Biden last year setting a 10-year deadline for cities to replace lead pipes. At the time, Biden said more than 9 million lead pipes were still in use across the country.
Lead can enter tap water when pipes and plumbing fixtures corrode. In children, lead exposure can cause hearing, speech, and behavioral problems, brain damage, and slowed growth. In adults, it has been linked to high blood pressure, joint pain, reproductive health issues, and cardiovascular disease.
Matthew Tejada, senior vice president of environmental health for the Natural Resources Defense Council — which was among the nonprofit groups that sued the city and state — said the lead pipe replacement was a victory for Flint residents and activists, who have gone to court multiple times since 2017 to ensure the work was completed.
Tejada said Flint residents should feel safe drinking and using the water now because it is 'being delivered through lead-free pipes.'
He said lead service lines remain a major threat to cities across the country and are often neglected in poor, majority-Black communities like Flint.
'We don't see these problems in wealthy White communities,' Tejada said. 'When they (Flint residents) were shouting from the rooftops looking for help, every level of government failed them. That doesn't happen in a community where there is affluence. That happens in the communities that have been oppressed.'
The Rev. Allen C. Overton of Christ Fellowship Missionary Baptist Church in Flint said residents have a deep mistrust of local and state government because of the health problems, trauma, and financial burdens they have faced since 2014.
Overton said some members of his congregation still suffer from skin rashes and hair loss caused by the lead-tainted water they drank and showered in. He added that residents had to buy new water heaters, washing machines, and plumbing systems that were damaged during the crisis.
They were never compensated for these losses, Overton said. He also believes the officials who switched the water supply and ignored Flint residents' concerns at the height of the crisis were not fully held accountable.
'Somebody should have had to go to jail,' Overton said.
In 2022, a panel of Michigan Supreme Court judges ruled that indictments against former top state officials, including former Gov. Rick Snyder, for their roles in the Flint water crisis were invalid.
Overton said settlement payments for residents are long overdue. 'Make Flint whole,' he said. 'Give the residents what they truly deserve.
Flint Mayor Sheldon Neeley said replacing the lead pipes was a milestone that has helped the city of about 80,000 residents move 'from crisis to recovery.'
Neeley said local officials are focused on regaining the community's trust and understand there are lingering concerns about water quality. He encourages Flint residents to continue using filters if they are not comfortable with the tap water.
However, he said Flint's water is 'testing the best in the state of Michigan, if not the best in the country.'
'We are doing everything we need to do to be in that good space where we can say, 'Yes, our water is tested and monitored,'' Neeley said. 'We are following all the environmental protection agencies at the state level and federal level to make sure we maintain the highest level of standard that we can.'
CNN has reached out to Michigan Gov. Gretchen Whitmer's office for comment.
Neeley said he submitted a letter in April urging the court-appointed administrator of the $600 million Flint water crisis settlement to release payments to residents.
'Justice delayed is justice denied — we must move from compliance to compensation,' Neely said.
For some people who drank the contaminated water in Flint, their lives have been forever changed.
Nakiya Wakes said she suffered two miscarriages — both with twins — in 2015 and 2017.
Wakes said she didn't stop drinking Flint's tap water until after she returned home from the hospital in 2015 and found a flyer in her mailbox advising pregnant women and elderly people to stop consuming the water.
'The damage had already been done to my system,' she said.
Frustrated by the city's ongoing water problems and separate issues with her landlord, Wakes moved to Niles, Michigan, in 2022.
But the family's health issues — which Wakes believes may be a result of drinking Flint's water in 2014 and 2015 — have followed them.
Wakes' son, now 16, suffers from severe shoulder and neck pain and has experienced behavioral and cognitive problems since he was 5, which forced him to be homeschooled. Wakes, 49, said she recently underwent emergency surgery for blood clots in her lungs.
'They poisoned Flint, and I couldn't protect my own child,' she said.
Mays said the celebration over the lead pipe replacement came at a cost for Flint residents like herself.
She said residents and activists have spent the past decade pleading for clean water, new pipes, and financial compensation for the people of Flint.
'We have people who are just tired of fighting because this is exhausting,' Mays said. 'Not a dime has been given out to residents, nobody is in jail, so it's hard to stay positive.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Brachytherapy Devices Market is Growing at CAGR of 6.7% During 2025 -2031 to Reach US$534.20 Million
Brachytherapy Devices Market is Growing at CAGR of 6.7% During 2025 -2031 to Reach US$534.20 Million

Yahoo

time7 minutes ago

  • Yahoo

Brachytherapy Devices Market is Growing at CAGR of 6.7% During 2025 -2031 to Reach US$534.20 Million

NEW YORK, Aug 4, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the Brachytherapy Devices Market is witnessing significant growth due to the rising incidence of cancer worldwide and technological advancements in brachytherapy devices. The Brachytherapy Devices Market value is expected to reach US$534.20 million by 2031 from US$343.57 million in 2024; the market is anticipated to register a CAGR of 6.7% during 2025–2031. The market growth is attributed to the rising incidence of cancer worldwide, the aging population, and the technological advancements in brachytherapy devices. The Brachytherapy Devices Market analysis focuses on advancements such as MRI-compatible applicators and real-time imaging integration that play a vital role in the market growth. The report runs an in-depth analysis of market trends, key players, and future opportunities. Check valuable insights in the Brachytherapy Devices Market report. You can easily get a sample PDF of the report - Overview of Brachytherapy Devices Market Report Findings Rising Incidence of Cancer Worldwide:As per the GLOBOCAN 2020 report, more than 28.4 million new cancer cases are expected to be reported by 2040. An aging population, lack of physical activity, exposure to pollutants in the environment, and alterations in diet lead to increased rates of an internal radiation treatment, is ideal for the treatment of prostate, cervical, breast, and skin cancers. It allows for the radiation to be targeted directly to the tumor and avoid the surrounding healthy tissues, with reduced side effects and improved recovery times. Thus, brachytherapy is becoming increasingly popular among oncologists and cancer remains among the major causes of mortality globally, demand for effective, low-invasive, and affordable treatment procedures is rising. Brachytherapy is meeting this demand, particularly in facilities where it might not be possible to access highly advanced external radiation facilities. Thus, the increasing burden of cancers worldwide propels the market growth. Technological Advancements in Brachytherapy Devices:Advances in the area are improving the accuracy, safety, and effectiveness of treatments, making brachytherapy a progressively appealing choice for cancer technological advancements include the creation of high-dose rate (HDR) and low-dose rate (LDR) machines, which provide more accurate radiation delivery. HDR machines provide for administering higher doses of radiation in shorter times, making treatment faster and more convenient for patients. MRI-compatible applicators and integration of sophisticated imaging are providing better tumor localization and online monitoring of treatment. These advances allow clinicians to target tumors effectively with less exposure to healthy tissues in the proximity. The robot-assisted platforms provide higher accuracy and precision, particularly in challenging anatomical areas. In addition, miniaturization and mobility of brachytherapy equipment are facilitating treatments, especially in developing advances in technology are making brachytherapy more effective and safer but and increasing its uses in treating a broader spectrum of cancers. Consequently, the greater uptake of these machines is contributing to their adoption and setting the limits of cancer treatment even higher. Geographical Insights: In 2024, North America led the market with a substantial revenue share, followed by Europe and Asia Pacific. Asia Pacific is expected to register the highest CAGR during the forecast period. Stay Updated on Brachytherapy Devices Market Trends: Brachytherapy Devices Market Segmentation Based on product, the Brachytherapy Devices Market is segmented into seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy. The brachytherapy afterloaders segment held the largest market share in 2024. In terms of type, the Brachytherapy Devices Market is categorized into high-dose rate brachytherapy implant and low-dose rate brachytherapy implant. The low-dose rate brachytherapy implant segment dominated the market in 2024. By application, the Brachytherapy Devices Market is segmented into breast cancer, cervical cancer, prostate cancer, lung cancer, and others. The prostate cancer segment dominated the market in 2024. Per end user, the Brachytherapy Devices Market is divided into hospitals and specialty clinics, ambulatory surgical centers, and others. The hospitals and specialty clinics segment dominated the market in 2024. The Brachytherapy Devices Market is segmented into five major regions: North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. Competitive Strategy and Development Key players: Elekta, Varian Medical Systems, Inc., BEBIG Medical, Theragenics Corporation, IsoAid, Siemens Healthineers AG, BXTA, BD, and Eckert and Ziegler are among the major companies operating in the Brachytherapy Devices Market. Trending topics: Advancements in Imaging Technologies, Government Initiatives and Cancer Treatment Programs, Technological Advancements in Brachytherapy Devices, Integration of Artificial Intelligence (AI) and Robotics in brachytherapy, etc. Headlines on Brachytherapy Devices Market Artemis Hospital Announces the Launch of Brachytherapy Services, Expanding Advanced Cancer Care Papua New Guinea Resumes Radiotherapy, Starts Brachytherapy Services with IAEA Support BEBIG Medical Launches SagiNova Brachytherapy System at Father Muller Hospital as a Part of New Healthcare Wing Medanta Patents MAOLO Brachytherapy Device For Advanced Cervical Cancer Treatment Elekta Expands Brachytherapy Portfolio With Acquisition of iCad Inc.'s Xoft Business CivaTech Oncology Receives FDA Approval for CivaSheet Brachytherapy Device Get Premium Copy of Brachytherapy Devices Market Size and Growth Report by 2031 at: Conclusion The growth of the Brachytherapy Devices Market is fueled by the increasing prevalence of cancer, advances in technology, and soaring demand for minimally invasive treatment options. The high-dose rate (HDR) systems, MRI-compatible applicators, and robotic-assisted devices are increasing the accuracy of treatment and speeding up patient recovery. Further, there is a growing demand for affordable and patient-centric therapies, particularly in areas that have poor access to conventional cancer therapy. With increasing uses in prostate, breast, and cervical cancers, the demand for brachytherapy is surging, with better results and accessibility in cancer therapy. The report from The Insight Partners provides several stakeholders—including manufacturers of seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy devices—with valuable insights to navigate this evolving market landscape and unlock new opportunities. Trending Related Reports: Brachytherapy After Loaders Market Strategies, Top Players, Growth Opportunities, Analysis and Forecast by 2031 Cancer Therapy Market Scope, Share, and Size by 2031 Pancreatic Cancer Therapy Market SWOT Analysis by 2031 Lung Cancer Therapy Market Research Report by 2030 Cancer Biopsies Market Trends, Share, and Growth – 2031 Cervical Cancer Diagnostics and Therapeutics Market Size 2031 Kidney Cancer Therapeutics And Diagnostics Market Size 2031 Cancer Biopsies Market Trends, Share, and Growth - 2031 Thyroid Cancer Diagnostics Market Growth and Share by 2031 About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact Us:If you have any queries about this report or if you would like further information, please get in touch with us:Contact Person: Ankit MathurE-mail: +1-646-491-9876 Logo: View original content: SOURCE The Insight Partners Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

RETIRED PHYSICIAN AND FORMER STATE LEGISLATOR JANAK JOSHI ANNOUNCES CAMPAIGN FOR U.S. SENATE
RETIRED PHYSICIAN AND FORMER STATE LEGISLATOR JANAK JOSHI ANNOUNCES CAMPAIGN FOR U.S. SENATE

Yahoo

time7 minutes ago

  • Yahoo

RETIRED PHYSICIAN AND FORMER STATE LEGISLATOR JANAK JOSHI ANNOUNCES CAMPAIGN FOR U.S. SENATE

DENVER, Aug. 4, 2025 /PRNewswire/ -- Retired Colorado Springs Physician and former state legislator Dr. Janak Joshi has announced his candidacy for the United States Senate, mounting an aggressive challenge against career politician John Hickenlooper. "I arrived in America legally and with nothing but a suitcase and $100. Through hard work and deep appreciation for our Country, I found the American dream. Career politicians like John Hickenlooper are on a warpath to destroy the very fabric that makes America that land of opportunity. In the state legislature, I fought toe-to-toe against his radical ideals and drew a line in the sand between him and the constituents that sent me to Denver. I was a thorn in Hickenlooper's side - I never voted for a tax, fee, or spending increase. I never voted for his wasteful pet projects thrown onto the shoulders of the Colorado taxpayer. It's time to send Hickenlooper packing - and I'm the candidate to get the job done. This country gave me and my family the opportunity to find the American dream. Hickenlooper and radical progressives in D.C. are trying to destroy it. I have led a life of commitment to serve others, uphold the rule of law, and defend Colorado's values. That's exactly what I'll do in the United States Senate." Dr. Janak Joshi arrived in America legally, with a suitcase and $100. He went on to serve as a Colorado Springs physician for 30 years and served in the Colorado state legislature. Joshi has a proven track record of creating good-paying jobs, standing up for law and order, defending conservative values, and fighting back against the woke liberal agenda. Learn more: View original content to download multimedia: SOURCE Janak Joshi for U.S. Senate

Millions of women get UTIs each year. An antibiotic 30 years in the making is finally offering hope.
Millions of women get UTIs each year. An antibiotic 30 years in the making is finally offering hope.

Yahoo

time7 minutes ago

  • Yahoo

Millions of women get UTIs each year. An antibiotic 30 years in the making is finally offering hope.

The new medication performs just as well as the current top treatment for UTIs. Most UTIs, or urinary tract infections, are anything but subtle. When you've got one, you constantly feel like you need to pee even if you just went, it burns when you go and your urine looks suspiciously cloudy. UTIs are also quite common: More than 50% of women will deal with at least one in their lifetime, and what's worse is that these infections can come back in a matter of months. Treating them has also become trickier. That's because there's a growing number of antibiotic-resistant UTIs, meaning the drugs commonly used to kill the bacteria behind the infection no longer work as well. 'Not only are these infections painful and unpleasant, they are becoming more difficult to treat,' says Dr. Cynthia DeTata, an ob-gyn at Stanford Medicine Children's Health and a clinical assistant professor in maternal-fetal medicine at Stanford Medicine, tells Yahoo. She explains that the most common cause of antibiotic resistance is taking the medications improperly, such as not finishing the entire course of pills as prescribed. 'Partially treating an infection allows rebound growth of bacteria that are now resistant to that antibiotic,' she explains. Experts say there's an increasing need for new treatments to get UTIs back under control. The challenge? 'The last time a new antibiotic was approved for an uncomplicated UTI was 30 years ago. Our treatments have remained unchanged, while bacteria have continued to evolve,' Dr. Gil Weiss, an ob-gyn at the Association for Women's Health Care and assistant professor of clinical medicine in the department of obstetrics and gynecology at Northwestern Memorial Hospital in Chicago, tells Yahoo. Now for some good news: There's a new antibiotic on the market called gepotidacin (sold under the brand name Blujepa) that gives doctors a new way to fight pesky UTIs. It's the first new class of antibiotics since the 1990s, and experts say it can help treat UTIs with a lower risk of resistance. The problem: While there are effective drugs for UTIs, antibiotic-resistant infections are making them harder to treat. By the numbers: UTIs affect up to 16 million women in the U.S. annually, and for 30 to 44% of them, the infection will come back in a matter of months. Studies suggest that 92% of bacteria behind UTIs are resistant to at least one antibiotic, and nearly 80% don't respond to at least two antibiotics. The solution: In March 2025, the Food and Drug Administration approved gepotidacin to treat uncomplicated UTIs. (Drugs Pivya and Orlynvah were approved in 2024 to treat UTIs, but they fall into existing antibiotic classes.) 'Gepotidacin is part of a new class of antibiotics called triazaacenaphthylenes,' DeTata says. 'This class is so new that currently, gepotidacin is the only one in it.' Antibiotics fight bacteria in two main ways: They can kill bacteria (bactericidal) or they can prevent them from multiplying (bacteriostatic), says DeTata. For example, some antibiotics interfere with the formation of bacteria cell walls, causing the wall to burst and killing the bacteria, while others disrupt the synthesis of proteins, which bacteria need to survive. 'Gepotidacin works in an entirely new way by acting on enzymes called topoisomerases, leading to breaks in the DNA strands of bacteria,' DeTata says. 'So gepotidacin is bactericidal, as these breaks in the DNA strands kill the bacteria.' The drug's main side effects in clinical trials were diarrhea (16% of participants) and nausea (9%), both which are common side effects for antibiotics in general. The research also found that gepotidacin performs just as well as (if not better than) nitrofurantoin, which is a frontline treatment for UTIs. Added bonus: Gepotidacin 'has the potential to be used for the treatment of gonorrhea, which has also been difficult to treat due to multi-antibiotic resistance,' says DeTata. For Weiss and many other doctors, having a new treatment option for UTIs is something to celebrate. 'I'm very excited that a new medication has come to market,' he says. 'Any new medication for something so common is a win-win situation.' Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store